메뉴 건너뛰기




Volumn 88, Issue 5, 2010, Pages 497-499

Queries about vaccines containing squalene

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSTIMULATING AGENT; INFLUENZA VACCINE; SQUALENE; IMMUNOLOGICAL ADJUVANT; VACCINE;

EID: 77954315875     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.10     Document Type: Letter
Times cited : (5)

References (11)
  • 1
    • 0016310328 scopus 로고
    • Freund's adjuvants: Relationship of arthritigenicity and adjuvanticity in rats to vehicle composition
    • Whitehouse MW, Orr KJ, Beck FW, Pearson CM. Freund's adjuvants: relationship of arthritigenicity and adjuvanticity in rats to vehicle composition. Immunology 1974; 27: 311-330.
    • (1974) Immunology , vol.27 , pp. 311-330
    • Whitehouse, M.W.1    Orr, K.J.2    Beck, F.W.3    Pearson, C.M.4
  • 3
    • 0032952871 scopus 로고    scopus 로고
    • Identification of arthritigenic adjuvants of self and foreign origin
    • Lorentzen JC. Identification of arthritigenic adjuvants of self and foreign origin. Scand J Immunol 1999; 49: 45-50.
    • (1999) Scand J Immunol , vol.49 , pp. 45-50
    • Lorentzen, J.C.1
  • 5
    • 0026653062 scopus 로고
    • Syntex adjuvant formulation
    • Allison AC, Byars NE. Syntex adjuvant formulation. Res Immunol 1992; 143: 519-525.
    • (1992) Res Immunol , vol.143 , pp. 519-525
    • Allison, A.C.1    Byars, N.E.2
  • 6
    • 36148950123 scopus 로고    scopus 로고
    • MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: What did we learn during its development?
    • O'Hagan DT, Wack A, Podda A. MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development? Clin Pharmacol Therap 2007; 82: 740-744.
    • (2007) Clin Pharmacol Therap , vol.82 , pp. 740-744
    • O'Hagan, D.T.1    Wack, A.2    Podda, A.3
  • 7
    • 0025868227 scopus 로고
    • Anthrax vaccines: Past, present and future
    • Turnbull PCB. Anthrax vaccines: past, present and future. Vaccine 1991; 9: 533-539.
    • (1991) Vaccine , vol.9 , pp. 533-539
    • Turnbull, P.C.B.1
  • 8
    • 0036075888 scopus 로고    scopus 로고
    • Anti-squalene antibodies in recipients of anthrax vaccine
    • Asa PB, Wilson RB, Garry RF. Anti-squalene antibodies in recipients of anthrax vaccine. Exp Mol Pathol 2002; 73: 19-27.
    • (2002) Exp Mol Pathol , vol.73 , pp. 19-27
    • Asa, P.B.1    Wilson, R.B.2    Garry, R.F.3
  • 9
    • 1842861810 scopus 로고    scopus 로고
    • Detection of antibodies to squalene: III Naturally occurring antibodies to squalene in humans and mice
    • Matyas GR, Rao M, Pittman PR, Burge R, Robbins IE, Wassef NM et al. Detection of antibodies to squalene: III Naturally occurring antibodies to squalene in humans and mice. J Immunol Methods 2004; 286: 47-67.
    • (2004) J Immunol Methods , vol.286 , pp. 47-67
    • Matyas, G.R.1    Rao, M.2    Pittman, P.R.3    Burge, R.4    Robbins, I.E.5    Wassef, N.M.6
  • 10
    • 0018186703 scopus 로고
    • Plasma squalene: Lipoprotein distribution and kinetic analysis
    • Saudek CD, Frier BM, Liu GCK. Plasma squalene: lipoprotein distribution and kinetic analysis. J Lipid Res 1978; 19: 827-835.
    • (1978) J Lipid Res , vol.19 , pp. 827-835
    • Saudek, C.D.1    Frier, B.M.2    Liu, G.C.K.3
  • 11
    • 67649297821 scopus 로고    scopus 로고
    • Emergence and pandemic potential of swine origin H1N1 influenza virus
    • Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine origin H1N1 influenza virus. Nature 2009; 459: 931-939.
    • (2009) Nature , vol.459 , pp. 931-939
    • Neumann, G.1    Noda, T.2    Kawaoka, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.